Bridges Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Bridges Investment Counsel's AMGN Position: Q4 2017 in Review
Bridges Investment Counsel reduced its Amgen (AMGN) stake by 38% in Q4 2017, selling an estimated $611K and leaving 5,548 shares worth $965K. The position accounts for 0.53% of the portfolio, ranked #57.
Bridges Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.46M in Q2 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.
- Bridges Investment Counsel held 5,548 shares of Amgen worth $965K as of Q4 2017.
- Bridges Investment Counsel sold 3,455 Amgen shares in Q4 2017, an estimated $611K.
- Amgen made up 0.53% of Bridges Investment Counsel's portfolio in Q4 2017, its #57 holding.
- Bridges Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 19 quarters since.
- Bridges Investment Counsel's Amgen position peaked at $4.46M in Q2 2017.
- 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.
Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.